← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 15, 2019Last known activity
Feb 27, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 5 trials)
Phase 4 (2 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (5)
- NCT05170230Lead sponsorN/AFeb 27, 2022
- NCT05242783Lead sponsorN/AFeb 1, 2022
- NCT05266534Lead sponsorN/ADec 30, 2021
- NCT05154279Lead sponsorN/ADec 27, 2021
- NCT03945812CollaboratorPhase 4Jun 15, 2019
Details
- Last known activity
- Feb 27, 2022